Curosurf
Curosurf (Poractant alfa) is a natural pulmonary surfactant used to treat and prevent Respiratory Distress Syndrome (RDS) in premature newborns.
Overview
Curosurf contains Poractant alfa, a natural pulmonary surfactant extracted from porcine lung tissue. It is specifically formulated to treat Respiratory Distress Syndrome (RDS) in premature infants, helping to restore normal lung function and improve oxygen intake.
Important Information
Prescription medicine: Curosurf is supplied only against a valid prescription from a registered doctor. Use it only as directed by your doctor.
Cold-chain product: Curosurf must be kept refrigerated between 2°C and 8°C. PakMeds delivers it in temperature-controlled packaging. Refrigerate it as soon as it arrives and do not freeze it.
Key Benefits of Curosurf
Helps replenish missing natural surfactant in the lungs of premature newborns.
Improves lung expansion and oxygen exchange in infants with respiratory distress.
Reduces the risk of lung collapse and complications associated with RDS.
Supports stabilized breathing in neonatal intensive care settings.
Curosurf Ingredients and Usage
Curosurf contains Poractant alfa, which belongs to the class of natural pulmonary surfactants. It is indicated for the treatment and prophylaxis of Respiratory Distress Syndrome (RDS) in premature infants who are at high risk or showing early clinical signs of respiratory failure.
This medication is intended exclusively for use in hospital settings, such as Neonatal Intensive Care Units (NICU). It helps replace deficient endogenous surfactant, decreasing alveolar surface tension and improving overall pulmonary compliance.
How Does Curosurf Work?
Pulmonary surfactant coats the inner surface of the air sacs (alveoli) inside the lungs. In premature infants, inadequate surfactant production causes the air sacs to collapse during exhalation, making breathing extremely difficult.
Curosurf lowers the surface tension within the alveoli. By stabilizing the air sacs, it prevents lung collapse, enhances surface area for oxygen absorption, and significantly reduces the effort required for the baby to breathe.
How to Use Curosurf
Curosurf is an intratracheal suspension administered directly into the infant's trachea (windpipe).
This medication must only be administered by trained healthcare professionals in a specialized hospital or neonatal intensive care unit.
The dosing amount and administration method are determined entirely by the attending neonatologist based on the infant's clinical status and body weight.
Curosurf Side Effects
Curosurf is administered in critical care settings, where infants are closely monitored. Inform the attending doctor if any adverse reactions or sudden changes occur.
Transient bradycardia (slow heart rate)
Transient hypotension (low blood pressure)
Endotracheal tube obstruction
Decreased oxygen saturation during administration
Intracranial hemorrhage
Pulmonary hemorrhage
Warnings
Curosurf should only be administered by medical personnel trained in neonatal intensive care and resuscitation.
Rapid improvement in oxygenation may occur, requiring immediate adjustment of ventilator settings to prevent oxygen toxicity.
Suctioning of the infant airway should generally be avoided for a period after administration to prevent removing the medicine, unless airways are obstructed.
Monitor continuous oxygen levels, arterial blood pressure, and lung function during and immediately after dosing.
Precautions and Who Should Avoid It
Infants should be closely evaluated for signs of systemic infection prior to or during treatment.
Use with caution in infants who present with severe congenital anomalies or cardiac instability.
Must be warmed to room temperature before administration as directed by medical staff.
Ensure proper placement of the endotracheal tube before instillation of the suspension.
Drug and Food Interactions
No specific drug interaction studies have been conducted for intratracheal surfactant therapy, but care must be taken with concurrent respiratory support measures.
Concomitant use with other intratracheally administered agents should be closely managed by the healthcare team.
Curosurf Storage Conditions
Curosurf is a cold chain product and must be stored refrigerated between 2°C and 8°C in its original pack to protect it from light. Do not freeze or shake the vial, and keep it strictly out of the reach of children.
Frequently Asked Questions
What is Curosurf used for?
Curosurf is used to treat and prevent Respiratory Distress Syndrome (RDS) in premature infants who lack natural lung surfactant.
How is Curosurf administered?
Curosurf is given directly into the baby's lungs through an endotracheal tube by trained medical personnel in a hospital NICU.
Can I buy Curosurf for home use?
No, Curosurf is strictly a hospital-use product that requires specialized clinical administration and monitoring.
Does Curosurf require cold chain shipping?
Yes, Curosurf requires continuous refrigeration between 2°C and 8°C and is delivered under controlled cold chain procedures by PakMeds.
Customer Reviews
No reviews yet. Be the first to review this product!
Login to write a review